Intranasal Insulin for Improving Cognitive Function in Multiple Sclerosis

NCT02988401 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
105
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Johns Hopkins University

Collaborators